Your browser doesn't support javascript.
loading
A progressive three-state model to estimate time to cancer: a likelihood-based approach.
Akwiwu, Eddymurphy U; Klausch, Thomas; Jodal, Henriette C; Carvalho, Beatriz; Løberg, Magnus; Kalager, Mette; Berkhof, Johannes; Coupé, Veerle M H.
Affiliation
  • Akwiwu EU; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Epidemiology and Data Science, Amsterdam Public Health, Amsterdam, The Netherlands. e.akwiwu@amsterdamumc.nl.
  • Klausch T; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Epidemiology and Data Science, Amsterdam Public Health, Amsterdam, The Netherlands.
  • Jodal HC; Clinical Effectiveness Research Group, University of Oslo and Oslo University Hospital, Oslo, Norway.
  • Carvalho B; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Løberg M; Clinical Effectiveness Research Group, University of Oslo and Oslo University Hospital, Oslo, Norway.
  • Kalager M; Clinical Effectiveness Research Group, University of Oslo and Oslo University Hospital, Oslo, Norway.
  • Berkhof J; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Epidemiology and Data Science, Amsterdam Public Health, Amsterdam, The Netherlands.
  • Coupé VMH; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Epidemiology and Data Science, Amsterdam Public Health, Amsterdam, The Netherlands.
BMC Med Res Methodol ; 22(1): 179, 2022 06 27.
Article in En | MEDLINE | ID: mdl-35761181
BACKGROUND: To optimize colorectal cancer (CRC) screening and surveillance, information regarding the time-dependent risk of advanced adenomas (AA) to develop into CRC is crucial. However, since AA are removed after diagnosis, the time from AA to CRC cannot be observed in an ethically acceptable manner. We propose a statistical method to indirectly infer this time in a progressive three-state disease model using surveillance data. METHODS: Sixteen models were specified, with and without covariates. Parameters of the parametric time-to-event distributions from the adenoma-free state (AF) to AA and from AA to CRC were estimated simultaneously, by maximizing the likelihood function. Model performance was assessed via simulation. The methodology was applied to a random sample of 878 individuals from a Norwegian adenoma cohort. RESULTS: Estimates of the parameters of the time distributions are consistent and the 95% confidence intervals (CIs) have good coverage. For the Norwegian sample (AF: 78%, AA: 20%, CRC: 2%), a Weibull model for both transition times was selected as the final model based on information criteria. The mean time among those who have made the transition to CRC since AA onset within 50 years was estimated to be 4.80 years (95% CI: 0; 7.61). The 5-year and 10-year cumulative incidence of CRC from AA was 13.8% (95% CI: 7.8%;23.8%) and 15.4% (95% CI: 8.2%;34.0%), respectively. CONCLUSIONS: The time-dependent risk from AA to CRC is crucial to explain differences in the outcomes of microsimulation models used for the optimization of CRC prevention. Our method allows for improving models by the inclusion of data-driven time distributions.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Adenoma Type of study: Diagnostic_studies / Incidence_studies / Prognostic_studies / Screening_studies Limits: Humans Language: En Journal: BMC Med Res Methodol Journal subject: MEDICINA Year: 2022 Type: Article Affiliation country: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Adenoma Type of study: Diagnostic_studies / Incidence_studies / Prognostic_studies / Screening_studies Limits: Humans Language: En Journal: BMC Med Res Methodol Journal subject: MEDICINA Year: 2022 Type: Article Affiliation country: Netherlands